Biomarkers and Beyond: Predicting Course and Tailoring Treatment in Inflammatory Bowel Diseases

  • 478

    Total Views and Downloads

About this Research Topic

Submission deadlines

  1. Manuscript Summary Submission Deadline 22 December 2024 | Manuscript Submission Deadline 11 April 2025

  2. This Research Topic is still accepting articles.

Background

Inflammatory bowel diseases (IBD) are chronic and debilitating immune-mediated conditions affecting the gastrointestinal tract, which include Crohn's disease (CD) and ulcerative colitis (UC). Both conditions exhibit a relapsing-remitting pattern with varied phenotypes and disease progression. Ongoing advances in understanding the molecular mechanisms behind pathogenic inflammatory processes have led to the emergence of targeted therapies. However, precision medicine in IBD remains in its early stages. Approximately one-third of patients are primary non-responders to initiated treatment, and half of patients lose response over time. Furthermore, rates for surgery because of complicated disease remain extremely high in CD (approximately 20-30% at 10 years after diagnosis). Similarly, patients affected by UC can develop rapidly progressive and severe or multi-refractory forms of disease. Non-invasive monitoring through serological and faecal biomarkers, and through surrogates of endoscopic activity (i.e., ultrasonographic parameters) represents currently the backbone of the management of IBD patients. Still, the complex and multifactorial pathogenesis, the heterogeneity of patients, the variable and unpredictable course of disease hamper the identification of reliable clinical, molecular or serological predictors.

Therapeutic decisions are currently guided by disease-related factors, comorbidities, safety considerations, drug characteristics, and patient preferences, but their predictive reliability is low. These factors serve merely as surrogate indicators and are insufficient for guiding clinical practice, emphasizing the need for predictive molecular biomarkers to determine the most appropriate treatment for each patient.

The goal of this Research Topic is to present innovative discoveries in the identification and validation of novel biomarkers in IBD, for IBD, which may serve as indicators of biological processes and can be applied in clinical practice to optimize therapy selection for patients with the highest likelihood of response. We here focused on research data for prediction of both therapeutic response/resistance as well as for disease course including the development of extra-intestinal manifestations, fibrosis and complications. This collection will help to refine strategies in managing patients with IBD, highlighting the possible beneficial effects of personalized approaches and reducing the time spent on ineffective treatments and minimizing the risk of adverse events. In the near future, an ideal approach will involve combining complementary biomarkers through multimodal analysis, integrating genetic, microbial, transcriptomic, proteomic, metabolic, and immunologic data to achieve a fully personalized approach.

In this Research Topic collection, we aim to investigate the identification, development, and validation of new biomarkers to enhance personalized treatment strategies in pre-clinical studies and in clinical settings in the management of IBD. We encourage submissions of Original Research, Review, Mini Review, and Perspective articles to explore the following specific questions, but not limited to:

• Genetic biomarkers of disease course, progression and therapeutic response in IBD.
• Microbial and/or luminal biomarkers of disease course, progression and therapeutic response in IBD.
• Transcriptomic biomarkers of disease course, progression and therapeutic response in IBD.
• Innovative biomarkers for predicting therapeutic response to anti-TNF agents, ustekinumab, vedolizumab, JAK inhibitors, and/or anti-IL-23 antibodies.
• Molecular pathways conferring therapeutic resistance in patients with IBD.
• Innovative biomarkers for predicting extra-intestinal involvement/s in patients with IBD.
• Innovative biomarkers for predicting intestinal fibrosis in patients with IBD.

Topic Editor Dr. Olga Nardone is in receipt of lecturing fees from Ferring, Abbvie, Janssen, Eli Lilly, Pfizer, AlfaSigma, Noòs and is on the advisory board for Nestle. Topic Editor Dr. Rocío Ferreiro-Iglesias has served as a speaker for or has received research funding from Takeda, MSD, Abbvie, Janssen, Pfizer, Palex, Shire Pharmaceuticals, TillottsPharma, Faes, AdacyteFerring and Casenrecordati. Topic Editor Dr. Arianna Dal Buono has served as a speaker from MSD, Abbvie, Pfizer, Ferring and Celltrion.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Clinical Trial
  • Conceptual Analysis
  • Editorial
  • General Commentary
  • Hypothesis and Theory
  • Methods
  • Mini Review

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Disease course, progression, biomarker, extra-intestinal manifestation, therapeutic response

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and they fall under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

      In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 478Topic views
View impact